Literature DB >> 20049773

The public acceptance of nanomedicine: a personal perspective.

David M Berube1.   

Abstract

Limited understanding of a subject leads to limited perceptions, including misinformed biases and associations. In regard to the field of nanotechnology, prior biotechnologies have harmed public perception of nanotechnology through association alone. While public bias is slow to convert toward truth, it is likely that the medical applications of nanotechnology will foster a renewed interest and trust in the field through the prolonged escape from death.

Mesh:

Year:  2009        PMID: 20049773     DOI: 10.1002/wnan.30

Source DB:  PubMed          Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol        ISSN: 1939-0041


  2 in total

1.  Recommendations for nanomedicine human subjects research oversight: an evolutionary approach for an emerging field.

Authors:  Leili Fatehi; Susan M Wolf; Jeffrey McCullough; Ralph Hall; Frances Lawrenz; Jeffrey P Kahn; Cortney Jones; Stephen A Campbell; Rebecca S Dresser; Arthur G Erdman; Christy L Haynes; Robert A Hoerr; Linda F Hogle; Moira A Keane; George Khushf; Nancy M P King; Efrosini Kokkoli; Gary Marchant; Andrew D Maynard; Martin Philbert; Gurumurthy Ramachandran; Ronald A Siegel; Samuel Wickline
Journal:  J Law Med Ethics       Date:  2012       Impact factor: 1.718

2.  The acceptability of nanocarriers for drug delivery in different contexts of use: perceptions of researchers and research trainees in the field of new technologies.

Authors:  Vanessa Chenel; Patrick Boissy; Marie-Sol Poirier; Jean-Pierre Cloarec; Johane Patenaude
Journal:  Int J Nanomedicine       Date:  2015-03-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.